Gyre Therapeutics – A biotechnology company focused on organ fibrosis and inflammatory diseases

Welcome to Gyre Therapeutics

We are a biotechnology company focused on organ fibrosis and inflammatory diseases. Learn more

Our Science

Hydronidone

MASH

Other Disease Areas

Latest news

Oct 15, 2025

Gyre Therapeutics Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Pirfenidone Capsules for the Treatment of Pneumoconiosis

Oct 14, 2025

Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD—The Liver Meeting® 2025

Sep 05, 2025

Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

More news